FDA Hits API Manufacturer With Warning Letter for GMP, Data Integrity Problems

Drug Industry Daily
A A
The FDA issued a warning letter to API manufacturer Megafine Pharma, citing data integrity violations and GMP issues.

To View This Article:

Login

Subscribe To Drug Industry Daily